Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Doran

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Psychiatry Research|August 1, 1988
Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteersA Breier, O M Wolkowitz, A R Doran, et al.
Advances in Biochemical Psychopharmacology|January 1, 1987
Somatostatin and GHRH: mood and behavioral regulationD R Rubinow, R M Post, C L Davis, et al.
Biological Psychiatry|April 1, 1986
Endogenous opioid regulation of hypothalamo-pituitary-adrenal axis activity in schizophreniaO M Wolkowitz, A R Doran, A Breier, et al.
Archives of General Psychiatry|June 1, 1990
Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophreniaA R Doran, R Labarca, O M Wolkowitz, et al.
Psychiatry Research|August 1, 1985
Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholiaA Roy, D Pickar, M Linnoila, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1987
Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acidA R Doran, J Boronow, D R Weinberger, et al.
Biological Psychiatry|February 15, 1989
Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: correlations with CSF HVAA R Doran, D R Rubinow, O M Wolkowitz, et al.
Psychopharmacology Series|January 1, 1987
Biochemical alterations produced by neuroleptics in man: studies of plasma homovanillic acid in schizophrenic patientsD Pickar, O M Wolkowitz, R Labarca, et al.
Life Sciences|October 19, 1987
Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illnessO M Wolkowitz, D R Rubinow, A Breier, et al.
The American Journal of Psychiatry|January 1, 1986
Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophreniaO M Wolkowitz, D Pickar, A R Doran, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Psychiatry Research|August 1, 1988
Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteersA Breier, O M Wolkowitz, A R Doran, et al.
Advances in Biochemical Psychopharmacology|January 1, 1987
Somatostatin and GHRH: mood and behavioral regulationD R Rubinow, R M Post, C L Davis, et al.
Biological Psychiatry|April 1, 1986
Endogenous opioid regulation of hypothalamo-pituitary-adrenal axis activity in schizophreniaO M Wolkowitz, A R Doran, A Breier, et al.
Archives of General Psychiatry|June 1, 1990
Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophreniaA R Doran, R Labarca, O M Wolkowitz, et al.
Psychiatry Research|August 1, 1985
Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholiaA Roy, D Pickar, M Linnoila, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1987
Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acidA R Doran, J Boronow, D R Weinberger, et al.
Biological Psychiatry|February 15, 1989
Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: correlations with CSF HVAA R Doran, D R Rubinow, O M Wolkowitz, et al.
Psychopharmacology Series|January 1, 1987
Biochemical alterations produced by neuroleptics in man: studies of plasma homovanillic acid in schizophrenic patientsD Pickar, O M Wolkowitz, R Labarca, et al.
Life Sciences|October 19, 1987
Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illnessO M Wolkowitz, D R Rubinow, A Breier, et al.
The American Journal of Psychiatry|January 1, 1986
Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophreniaO M Wolkowitz, D Pickar, A R Doran, et al.
Pageof 5